Skip to Main Content

Advertisement

Skip Nav Destination

Editor's Corner


Peddling Panaceas

February 2023

Aaron Gerds, MD,

Dr. Aaron Gerds discusses the role of advertising in health care, the challenges it can pose, whether physicians are responsible, and what can be done about the complex relationship going forward.

Hydroxyurea Adherence Linked With Better Clinical Outcomes in SCD

February 2023

A retrospective study looked at Texas Medicaid claims data for 1,032 individuals ages 2 to 63. Included individuals had one or more inpatient or two or more outpatient SCD diagnoses and had at least one hydroxyurea prescription.

CAR T-Cell Therapy Outcomes in LBCL Similar in Patients Who Do and Do Not Develop CRS

February 2023

Researchers sought to determine the effect of CRS on survival and whether CRS is correlated with the efficacy of CAR T-cell therapy. The retrospective study included 351 patients 18 years and older with LBCL who underwent apheresis for commercial CAR T-cell therapy between May 2018 and January 2021.

HU May Lower Malaria Incidence in Children With Sickle Cell Anemia

February 2023

In children with sickle cell anemia in Africa, the maximum tolerated dose of hydroxyurea is associated with a lower incidence of malaria. The incidence was found to decline when the absolute neutrophil count was below a certain level.

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement